According to WHO, combining casirivimab and imdevimab may reduce the risk of hospitalization and duration of symptoms in unvaccinated, older, or immunosuppressed patients.
Antibody tests indicate past exposure or immune response to vaccine. They, however, cannot detect neutralising antibodies which protect against future infections.
Several institutes and experts advocate see this as an efficacy trial that could help boost confidence in vaccines, especially Bharat Biotech’s Covaxin that is in phase-3 trials.
Until now, most tests could tell only whether antibodies are present. The newer ones measure the quantity of proteins raised by the immune system to disable viral invaders.
In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.
Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.
While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.
COMMENTS